Has Brian Frank received payments from drug or device companies?

Yes. Drug and device makers reported $3,972 in general payments to Brian Frank across 215 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brian Frank did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brian Frank come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brian Frank

Psychiatric/Mental Health · Syracuse, NYNPI 1871142687

Payments from drug & device makers

$3,972in general payments, 2019–2025

Across 215 payments — averaging $18.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Teva Pharmaceuticals USA, Inc.$1K
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$646
Alkermes, Inc.$431
AbbVie$279
Axsome Therapeutics, Inc.$206
Neurocrine Biosciences, Inc.$204
plus $998 from 12 others

What the payments were for

Food & beverage$3,82796%
Education$1454%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Teva Pharmaceuticals USA, Inc.	69	$1,208
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	43	$646
Alkermes, Inc.	21	$431
AbbVie	15	$279
Axsome Therapeutics, Inc.	10	$206
Neurocrine Biosciences, Inc.	10	$204
Vanda Pharmaceuticals Inc.	6	$189
E.r. Squibb & Sons, L.L.C.	8	$157
Indivior Inc.	6	$130
Johnson & Johnson	5	$113
Sunovion Pharmaceuticals Inc.	6	$95
Lundbeck LLC	4	$87
Collegium Pharmaceutical, Inc.	3	$59
Biogen	2	$46
Otsuka America Pharmaceutical, Inc.	2	$39
Corium, LLC	2	$32
Takeda Pharmaceuticals U.S.A., Inc.	2	$31
Ironshore Pharmaceuticals Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CAPLYTA$125

How this compares

$3,972 in reported general payments places this provider in the 90th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Austedo XrDeutetrabenazine	37	$297,426
Invega SustennaPaliperidone Palmitate	21	$62,996
LybalviOlanzapine/Samidorphan Malate	24	$37,116
RexultiBrexpiprazole	16	$24,745
VraylarCariprazine Hcl	15	$20,339
AuvelityDextromethorphan Hbr/Bupropion	11	$18,037
Paliperidone ErPaliperidone	24	$7,767
Lurasidone Hcl	24	$7,384
Bupropion XlBupropion Hcl	49	$3,225
Aripiprazole	42	$2,037
Vilazodone Hcl	11	$2,001
Olanzapine	81	$1,859
Clozapine	34	$1,635
Mirtazapine	64	$758
Prazosin Hcl	55	$627

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr	$1,208	$297,42637 claims
Johnson & JohnsonInvega Sustenna	$113	$62,99621 claims
Alkermes, Inc.Lybalvi	$431	$37,11624 claims
Otsuka America Pharmaceutical, Inc.Rexulti	$39	$24,74516 claims
AbbVieVraylar	$279	$20,33915 claims
Axsome Therapeutics, Inc.Auvelity	$206	$18,03711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Syracuse

Sherie RamsgardSyracuse$52K
Laneasha EudellSyracuse$15K
Glenn HannDansville$1.3M
Tammy RussoNiskayuna$568K
Carrie EdickSchenectady$484K
Eric SpronzCentereach$448K
Terry Jo Brooks-DevlinTonawanda$176K
Kevin SiewersStaten Island$155K
Daniel BreeyearNiskayuna$149K
Mary OlsonNew York$142K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →